Q3 2024 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2024-11-14 · accession 0001420506-24-002535
$113.7M
Reported value
8
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $37.0M | 32.5% | 291,094 | Common | SOLE |
| 14167L103 | CDNA | CAREDX INC | $18.9M | 16.6% | 604,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $17.4M | 15.3% | 255,243 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $12.8M | 11.2% | 4,697,785 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $11.0M | 9.66% | 2,145,145 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $10.3M | 9.10% | 451,047 | Common | SOLE |
| 71535D106 | PSNL | PERSONALIS INC | $5.4M | 4.73% | 1,000,000 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $1.0M | 0.89% | 78,393 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.